Laboratories, research initiatives and companies are partnering to ease access to clinical trials — through simpler regulations and databases of treatments being tested.

There may be no single cure, but there are nearly as many cancer treatments as there are types of the disease. Since 1975, the five-year survival rate for all cancers has risen by 36 percent. Yet researchers have struggled with a far more fundamental moonshot than developing innovative ways to treat cancer: Their challenge has been to test new treatments. Now, that might be about to change.

More than four out of five cancer clinical trials fail because researchers simply cannot recruit enough patients. Fewer than 5 percent of cancer patients are enrolled in clinical trials, partly due to restrictive criteria for selecting patients that doctors say are often counterproductive. Worse, there is no central resource through which doctors and patients can find up-to-date information on nearby trials for which patients might be eligible. Transportation back and forth from clinical trials and mistrust also deter many patients. But a growing band of laboratories, research initiatives and companies are now battling to make access to information about — and participation in — cancer clinical trials easier in a bid to revolutionize a key bottleneck in oncology research. Their efforts could also hold implications for clinical trials across other fields of medicine.

Trainer Brandon Payne never made it as a big-time basketball player, but his NBA roster continues to grow.

Brandon Payne is haunted by his past, and Stephen Curry is paying for it.

While the six-time NBA All-Star and two-time league MVP makes splashing buckets look oh so easy, it’s Curry’s longtime trainer — and his unwavering attention to detail — who continues to have the biggest impact on Curry’s free-flowing game. And now he’s shaping the next generation of transcendent guards.

“Some days I don’t wanna come to the gym and give it 110 percent,” admits Curry, who has worked with Payne since 2011. But “can you push yourself — when you don’t wanna work and you don’t wanna grind — and know that it’s gonna pay off in the long run?”

The K-Pop musical sensations’ hiatus is either a sincere request for rest or a clever PR stunt.

If you were in the middle of a hurricane, you’d probably not need to be told that you were in the middle of a hurricane; the violent hysteria whipped up by the weather system would be enough. But when you suddenly find yourself in the midst of K-Pop craziness, specifically a South Korean boy band by the name of BTS — alternatively the Bangtan Boys, Bangtan Sonyeondan, Beyond the Scene or the Bulletproof Boy Scouts — some explaining might be in order.

For starters, their recent single “Boy With Luv” not only debuted at No. 8 on Billboard’s Hot 100, but the video for it drew nearly 75 million viewers in the first 24 hours of going live, making it the most viewed online video. Like, ever. In the history of civilization.